Healthcare Triangle, Inc. announced that its shareholders approved all nine proposals at its virtual Annual Meeting on July 17, 2026. The key approvals authorize the company to issue common stock related to the Teyame transaction, a settlement agreement, and various financing arrangements, in addition to amending its stock incentive plan.
Key Details
- Teyame Transaction: Shareholders approved the issuance of up to 11,869,397 shares of common stock in connection with the Share Purchase Agreement for the Teyame AI Holdings Inc. transaction.
- Settlement Agreement: The issuance of 2,828,167 shares of common stock to SecureKloud Technologies Ltd. pursuant to a Settlement Agreement dated June 24, 2026, was approved.
- Financing Agreements: Approvals were granted for potential common stock issuances related to an ELOC Purchase Agreement with Hudson Global Ventures and Senior Secured Convertible Debentures, both tied to agreements from June 2026.
- Stock Incentive Plan: Shareholders approved an amendment to the 2020 Stock Incentive Plan to automatically increase the number of shares reserved under the plan annually.